ALBANY – Albany State University has announced the launch of a new Master of Science in Integrated Biotechnology program, set ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Donald Trump's announcement that Elon Musk and Vivek Ramaswamy will lead a newly formed Department of Government Efficiency ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

One of Chicago's richest dynasties built one of the world’s biggest health-care fortunes over the past century, but these ...

Ray Dalio’s firm cuts 20% of its Microsoft stock holding, signaling a shift in tech focus. Cathie Wood’s Ark Invest also ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

Bank of America sees strong M&A potential in banking and biotech, with financials historically more active under Republicans.

Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...